OYST Stock, Oyster Point Pharma Inc. Information
Stock Information
Get OYST Alerts
News, Short Squeeze, Breakout and More Instantly...
About Oyster Point Pharma Inc.
Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.